Cargando…
Correction to: Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8793270/ https://www.ncbi.nlm.nih.gov/pubmed/35086550 http://dx.doi.org/10.1186/s13046-022-02247-y |
| _version_ | 1784640561226973184 |
|---|---|
| author | Romito, Ilaria Porru, Manuela Braghini, Maria Rita Pompili, Luca Panera, Nadia Crudele, Annalisa Gnani, Daniela De Stefanis, Cristiano Scarsella, Marco Pomella, Silvia Mortera, Stefano Levi de Billy, Emmanuel Conti, Adrian Libenzio Marzano, Valeria Putignani, Lorenza Vinciguerra, Manlio Balsano, Clara Pastore, Anna Rota, Rossella Tartaglia, Marco Leonetti, Carlo Alisi, Anna |
| author_facet | Romito, Ilaria Porru, Manuela Braghini, Maria Rita Pompili, Luca Panera, Nadia Crudele, Annalisa Gnani, Daniela De Stefanis, Cristiano Scarsella, Marco Pomella, Silvia Mortera, Stefano Levi de Billy, Emmanuel Conti, Adrian Libenzio Marzano, Valeria Putignani, Lorenza Vinciguerra, Manlio Balsano, Clara Pastore, Anna Rota, Rossella Tartaglia, Marco Leonetti, Carlo Alisi, Anna |
| author_sort | Romito, Ilaria |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8793270 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87932702022-02-03 Correction to: Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects Romito, Ilaria Porru, Manuela Braghini, Maria Rita Pompili, Luca Panera, Nadia Crudele, Annalisa Gnani, Daniela De Stefanis, Cristiano Scarsella, Marco Pomella, Silvia Mortera, Stefano Levi de Billy, Emmanuel Conti, Adrian Libenzio Marzano, Valeria Putignani, Lorenza Vinciguerra, Manlio Balsano, Clara Pastore, Anna Rota, Rossella Tartaglia, Marco Leonetti, Carlo Alisi, Anna J Exp Clin Cancer Res Correction BioMed Central 2022-01-27 /pmc/articles/PMC8793270/ /pubmed/35086550 http://dx.doi.org/10.1186/s13046-022-02247-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Romito, Ilaria Porru, Manuela Braghini, Maria Rita Pompili, Luca Panera, Nadia Crudele, Annalisa Gnani, Daniela De Stefanis, Cristiano Scarsella, Marco Pomella, Silvia Mortera, Stefano Levi de Billy, Emmanuel Conti, Adrian Libenzio Marzano, Valeria Putignani, Lorenza Vinciguerra, Manlio Balsano, Clara Pastore, Anna Rota, Rossella Tartaglia, Marco Leonetti, Carlo Alisi, Anna Correction to: Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects |
| title | Correction to: Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects |
| title_full | Correction to: Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects |
| title_fullStr | Correction to: Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects |
| title_full_unstemmed | Correction to: Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects |
| title_short | Correction to: Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects |
| title_sort | correction to: focal adhesion kinase inhibitor tae226 combined with sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8793270/ https://www.ncbi.nlm.nih.gov/pubmed/35086550 http://dx.doi.org/10.1186/s13046-022-02247-y |
| work_keys_str_mv | AT romitoilaria correctiontofocaladhesionkinaseinhibitortae226combinedwithsorafenibslowsdownhepatocellularcarcinomabymultipleepigeneticeffects AT porrumanuela correctiontofocaladhesionkinaseinhibitortae226combinedwithsorafenibslowsdownhepatocellularcarcinomabymultipleepigeneticeffects AT braghinimariarita correctiontofocaladhesionkinaseinhibitortae226combinedwithsorafenibslowsdownhepatocellularcarcinomabymultipleepigeneticeffects AT pompililuca correctiontofocaladhesionkinaseinhibitortae226combinedwithsorafenibslowsdownhepatocellularcarcinomabymultipleepigeneticeffects AT paneranadia correctiontofocaladhesionkinaseinhibitortae226combinedwithsorafenibslowsdownhepatocellularcarcinomabymultipleepigeneticeffects AT crudeleannalisa correctiontofocaladhesionkinaseinhibitortae226combinedwithsorafenibslowsdownhepatocellularcarcinomabymultipleepigeneticeffects AT gnanidaniela correctiontofocaladhesionkinaseinhibitortae226combinedwithsorafenibslowsdownhepatocellularcarcinomabymultipleepigeneticeffects AT destefaniscristiano correctiontofocaladhesionkinaseinhibitortae226combinedwithsorafenibslowsdownhepatocellularcarcinomabymultipleepigeneticeffects AT scarsellamarco correctiontofocaladhesionkinaseinhibitortae226combinedwithsorafenibslowsdownhepatocellularcarcinomabymultipleepigeneticeffects AT pomellasilvia correctiontofocaladhesionkinaseinhibitortae226combinedwithsorafenibslowsdownhepatocellularcarcinomabymultipleepigeneticeffects AT morterastefanolevi correctiontofocaladhesionkinaseinhibitortae226combinedwithsorafenibslowsdownhepatocellularcarcinomabymultipleepigeneticeffects AT debillyemmanuel correctiontofocaladhesionkinaseinhibitortae226combinedwithsorafenibslowsdownhepatocellularcarcinomabymultipleepigeneticeffects AT contiadrianlibenzio correctiontofocaladhesionkinaseinhibitortae226combinedwithsorafenibslowsdownhepatocellularcarcinomabymultipleepigeneticeffects AT marzanovaleria correctiontofocaladhesionkinaseinhibitortae226combinedwithsorafenibslowsdownhepatocellularcarcinomabymultipleepigeneticeffects AT putignanilorenza correctiontofocaladhesionkinaseinhibitortae226combinedwithsorafenibslowsdownhepatocellularcarcinomabymultipleepigeneticeffects AT vinciguerramanlio correctiontofocaladhesionkinaseinhibitortae226combinedwithsorafenibslowsdownhepatocellularcarcinomabymultipleepigeneticeffects AT balsanoclara correctiontofocaladhesionkinaseinhibitortae226combinedwithsorafenibslowsdownhepatocellularcarcinomabymultipleepigeneticeffects AT pastoreanna correctiontofocaladhesionkinaseinhibitortae226combinedwithsorafenibslowsdownhepatocellularcarcinomabymultipleepigeneticeffects AT rotarossella correctiontofocaladhesionkinaseinhibitortae226combinedwithsorafenibslowsdownhepatocellularcarcinomabymultipleepigeneticeffects AT tartagliamarco correctiontofocaladhesionkinaseinhibitortae226combinedwithsorafenibslowsdownhepatocellularcarcinomabymultipleepigeneticeffects AT leonetticarlo correctiontofocaladhesionkinaseinhibitortae226combinedwithsorafenibslowsdownhepatocellularcarcinomabymultipleepigeneticeffects AT alisianna correctiontofocaladhesionkinaseinhibitortae226combinedwithsorafenibslowsdownhepatocellularcarcinomabymultipleepigeneticeffects |